de la Peña June Bryan, Ahsan Hafiz Muhammad, Dela Peña Irene Joy, Park Hyun Bin, Kim Hee Jin, Sohn Aeree, Kim Yun Tai, Cheong Jae Hoon
Uimyung Research Institute for Neuroscience, Sahmyook University , Nowon-gu, Seoul and.
Am J Drug Alcohol Abuse. 2014 Jul;40(4):321-6. doi: 10.3109/00952990.2014.920850. Epub 2014 Jun 20.
Propofol and the tiletamine-zolazepam combination are anesthetics with both sedative-hypnotic and hallucinogenic effects. In South Korea, propofol is controlled while the tiletamine-zolazepam combination is not. Thus, there is a possibility that this drug combination might be used as a substitute drug by propofol-abusers.
In the present study we evaluated whether repeated pre-exposure to propofol predisposes to the use/abuse of the tiletamine-zolazepam combination.
Rats (8-10 animals/group) were pre-treated with saline (control) or propofol at different dosages (10, 30, 60 mg/kg, i.p.), for 14 days, then conditioned place preference (CPP) and self-administration (SA) for the tiletamine-zolazepam combination were evaluated.
Rats pretreated with saline exhibited neither CPP nor SA for the tiletamine-zolazepam combination. On the other hand, rats pretreated with propofol, in all dosages, demonstrated significant CPP and SA for the tiletamine-zolazepam combination.
These results suggest that tiletamine-zolazepam combinations might be used as a "substitute drug" by abusers of propofol. The careful use, dispensation, and monitoring of tiletamine-zolazepam combinations are advocated.
丙泊酚和替来他明-唑拉西泮组合是兼具镇静催眠和致幻作用的麻醉剂。在韩国,丙泊酚受到管控,而替来他明-唑拉西泮组合则不受管控。因此,这种药物组合有可能被丙泊酚滥用者用作替代药物。
在本研究中,我们评估了重复预先暴露于丙泊酚是否会导致替来他明-唑拉西泮组合的使用/滥用。
将大鼠(每组8 - 10只动物)用生理盐水(对照组)或不同剂量(10、30、60mg/kg,腹腔注射)的丙泊酚预处理14天,然后评估对替来他明-唑拉西泮组合的条件性位置偏爱(CPP)和自我给药(SA)情况。
用生理盐水预处理的大鼠对替来他明-唑拉西泮组合既未表现出CPP也未表现出SA。另一方面,用所有剂量丙泊酚预处理的大鼠对替来他明-唑拉西泮组合均表现出显著的CPP和SA。
这些结果表明,替来他明-唑拉西泮组合可能会被丙泊酚滥用者用作“替代药物”。提倡谨慎使用、配发和监测替来他明-唑拉西泮组合。